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Abstract 
Rab31 is a member of the large Rab protein family 
(66 human members) of the Ras superfamily of small 
GTPases. Rab31 is expressed fairly ubiquitously in 
normal human tissue and regulates membrane traffic 
between the Golgi/TGN and the plasma membrane 
and/or endosomes. Dysregulated expression of 
Rab31 has not only been observed in several types 
of cancer, including breast, ovarian, cervical and 
liver cancer as well as glioblastoma, but also in skin 
diseases such as psoriasis and atopic dermatitis. 
Keywords 
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Identity 
Other names: RAB22B 
HGNC (Hugo): RAB31 
Location: 18p11.22 
DNA/RNA 
Note 
Cloning:  A human cDNA encoding for Rab31 was 
first isolated in 1996 (Chen et al. 1996, Bao et al. 
1996). Chen et al. (1996) isolated a cDNA encoding 
for a novel human Rab protein from a human 
melanocyte cDNA library and human melanocytes. 
Since its sequence showed a significant homology  
to canine Rab22 it was named Rab22B. A BLAST 
analysis revealed that Rab22B shared 71% identity 
and 82% similarity with canine Rab22.  
Around the same time, Bao et al. (1996, 1997) 
identified a cDNA encoding for a previously 
unknown human Rab protein in human platelets. 
Because the accepted guideline for the use of the 
next available Rab numbers at that time was an 
identity less than 85%, the new protein was named 
Rab31 instead of Rab22B (Chen et al. 1996; Bao et 
al. 2002). 
Rodriguez-Gabin et al. (2001) identified a Rab 
sequence (rRab22B) cloned from a rat 
oligodendrocyte cDNA library with a high identity 
to human Rab31. Since comparison of the rRab22B 
sequence with human Rab31 (on the protein level) 
showed 88% identity it has been suggested that 
rRab22b encodes the rat homolog of human Rab31. 
In view of the fact that a segment of the carboxy-
terminal domain shows 9 differences among the last 
18 residues, one must, however, consider that 
rRab22B (and also murine Rab22B which is 97.9% 
identical with rRab22B) still may encode a new 
member of the Rab family, especially, because the 
carboxy-terminal end is part of the motif responsible 
for the targeting of Rab proteins to specific 
membrane compartments (Rodriguez-Gabin et al. 
2001). Despite of this notion the authors refer to 
rRab22B as Rab31 (Rodriguez-Gabin et al. 2009). 
Description 
DNA size: 154,326, 7 exons (Fig. 1) 
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Figure 1. Location of the Rab31 gene (RAB31) on chromosome 18p11.22The introns dividing the seven exons display 
following phases: IE1-2: 0; IE2-3: 2; IE3-4: 0; IE4-5: 0; IE4-5: 2; IE6-7: 1. The intron phases between RAB31 and its closest homolog 
RAB22A, located on chromosome 20, are conserved. 
 
Protein 
Description 
The coding sequence of human Rab31 corresponds 
to a 194 amino acid (aa) protein with a nominal 
molecular mass of 21.6 kDa and a pI of 6.7. 
The crystal structure of human Rab31 bound to a 
non-hydrolyzable GTP analog, guanosine-5'-(β γ)-
imidotriphosphate (GppNHp) at 2.8 Å was described 
by Tempel et al. (2006) and is presented in Fig. 2A. 
Rab31 possesses a typically GTPase fold, composed 
of a six-stranded β-sheet core flanked by five α-
helices. The binding site for guanine nucleotides and 
Mg2+ is well conserved among Rab proteins (Fig. 
2B; aa 12-19, 60-64, and 118-121). The GTPase fold 
is followed by a hypervariable region, which harbors 
two cysteine residues to which geranylgeranyl 
moieties are covalently attached. Modification by 
geranylgeranylation is required for its proper 
subcellular localization, mainly the trans-Golgi 
network (Chua and Tang 2015). 
 
Figure 2. Primary and tertiary structure of Rab31 (A)  Sequence alignment of Rab31 and the other members of the so-called 
group II of the human Rab family (Klöpper et al. 2012). Secondary structure is shown for Rab31 for β-strands (yellow arrows) 
and α-helices (red helices). Highly conserved residues are displayed with a grey background, the composite binding sites for 
guanine nucleotides and Mg2+ is (aa 12-19, 60-64, and 118-121 of Rab31) are marked with a green background. Ser35 
(indicated by a red triangle) has been mapped as phosphorylation site (www.phosphosite.org). The C-terminal region (~ 30 aa) is 
hypervariable except the two invariant cysteine residues to which geranylgeranyl moieties are post-translationally attached for 
membrane association. Black dots within the sequences of Rab17, 20, 21, and 24 indicate unique larger insertions not present in 
the other Rab proteins of the group II superfamily. 
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(B)  Crystal structure of human Rab31 bound to the non-hydrolyzable GTP analog GppNHp/ GNP (Tempel et al. 2006). β-
strands are indicated in yellow, α-helices in red; the composite binding site for guanine nucleotides and Mg2+ (cyan sphere) is 
marked in green. The side chain of Ser35, which is a target for phosphorylation is indicated as well. The two C-terminal 
cysteines, which are modified by prenylation, are not defined in the crystal structure. 
 
Expression 
Non-malignant tissue. Rab31 is expressed fairly 
ubiquitously in normal human tissue. At the 
transcript level, highest expression of Rab31 was 
found in testis, ovary, small intestine, brain, 
placenta, lung, adrenal gland, urinary bladder, 
endometrium, and smooth muscle (Chen et al. 1996; 
Bao et al. 2002; Human Protein Atlas: 
www.proteinatlas.org, Uhlén et al. 2015). High or 
medium protein expression levels of Rab31were 
detected by immunohistochemistry in 35 of 45 
analyzed non-malignant tissue types (Human Protein 
Atlas). 
Cancer tissue. Highest Rab31 immunoexpression 
was observed in malignant tissue of glioma, breast, 
and thyroid cancer as well as melanoma (Human 
Protein Atlas). 
Localisation 
Most normal cells display weak to moderate 
cytoplasmic staining, in a few cases of peri-nuclear 
staining (Human Protein Atlas). Within the 
cytoplasm, Rab31 was shown to be localized mainly 
in the Golgi, the trans-Golgi network (TGN) and 
endocytic compartments (Rodriguez-Gabin et al. 
2001). 
Function 
The members of the Rab family of small GTPases 
regulate various steps of dynamic assembly and 
disassembly of multi-protein scaffolds, which are 
involved in vesicular traffic in both endocytic and 
secretory pathways. Rab31 regulates anterograde 
("inside-out") and retrograde ("outside-in") 
membrane traffic between the Golgi/TGN and the 
plasma membrane and/or endosomes. 
Rab proteins cycle between two alternate 
conformational states, inactive (GDP-bound) and 
active (GTP-bound) (Fig. 3).  
The activity of the Rab proteins is controlled by 
several regulatory factors: (i) Rab escort proteins 
(REPs), which transport newly synthesized Rab 
proteins to geranylgeranyl transferases for C-
terminal prenylation enabling specific membrane 
association; (ii) guanine exchange factors (GEFs) 
which catalyze the exchange of GDP for GTP, 
turning the GTPase into the active state; (iii) GTPase 
activating proteins (GAPs), which promote efficient 
GTP hydrolysis resulting in an inactive state; (iv) 
GDP dissociation inhibitors (GDIs), which extracts 
GDP-Rab from the membrane; (v) GDI 
displacement factors (GDFs), which assist re-
targeting and re-insertion of Rab into the appropriate 
membrane (Stenmark 2009; Hutagalung and Novick, 
2011; Chua and Tang 2015). 
 Rab31 interacting proteins  
- GEFs. 
Activation of Rab31 is mediated by several GEFs. 
Interaction of Rab31 with the different GEFs is 
mediated by the so-called Vps9 domain (Carney et 
al. 2006).  
Using pull-down assays, Lodhi et al. (2007) 
demonstrated that Gapex-5 (alternative name: 
GAPVD1, GTPase activating protein and Vps9 
domain 1) directly interacts with Rab31. Another 
study (Kajiho et al. 2011) found that two members 
of the RIN family (RIN2, RIN3; Ras and Rab 
interactor) as well as ALS2 (amyotrophic lateral 
sclerosis 2) and ALS2CL (ALS2 C-terminal like), 
but not RIN1 or Rabex-5 (also known as RABGEF1) 
can act as GEFs for Rab31. 
- Cation-dependent mannose-6-phosphate-receptors 
(CD-M6PRs). 
Rab31 is present in small tubulovesicular organelles 
trafficking from the Golgi/trans-Golgi network 
(TGN) to endosomes and is involved in the 
regulation of the formation these vesicles 
(Rodriguez-Gabin et al. 2001).  
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Figure 3. The Rab cycle (A)  Newly synthesized Rab proteins are transported by Rab escort proteins (REPs) to geranylgeranyl 
transferases.  (B)  Guanine exchange factors (GEFs) turn the membrane-associated Rab protein into its active state.  (C)  
GTPase activating proteins (GAPs) promote efficient GTP hydrolysis resulting in an inactive state of the Rab protein.  (D)  GDP 
dissociation inhibitors (GDIs), extract inactive GDP-bound Rab from the membrane.  (E)  GDI displacement factors (GDFs) 
release the Rab protein from the GDIs and assist re-targeting and re-insertion of the Rab into the appropriate membrane (figure 
modified from Hutagalung and Novick, 2011). 
 
Besides its role in the Golgi/TGN organization, 
Rab31 regulates the transport of CD-M6PRs from 
the TGN to endosomes (Rodriguez-Gabin et al. 
2009). Here, RIN3 likely acts as a GEF to regulate 
Rab31 dependent CD-M6PR-transport (Kajiho et al. 
2011). The M6PR system is one of the membrane 
transport pathways delivering newly synthesized 
proteins from the TGN to various endocytic 
compartments. Thus, this transport links 
biosynthetic to endocytic pathways and, therefore, is 
majorly involved in the biogenesis of endosomes, 
lysosomes, and the plasma membrane (Rodriguez-
Gabin et al. 2010). Rab31 was also shown to interact 
with OCRL, a phosphatidylinositol 4,5-diphosphate 
5-phosphatase (PI(4,5)P2 5-phosphatase) that 
regulates the levels of PI(4,5)P2 and PI(4)P, 
molecules involved in transport and Golgi/TGN 
organization. Co-localization of Rab31 and OCRL-1 
in carriers transporting M6PRs as well as in 
endosomes may indicate that both proteins are also 
involved in the targeting and/or fusion of the carriers 
with endosomes (Rodriguez-Gabin et al. 2010). 
- EGF receptor (EGFR). 
In addition to its function in the anterograde CD-
M6PR-transport, Rab31 plays an important role in 
the regulation of retrograde EGFR trafficking. Direct 
interaction of Rab31 with internalized ligand-bound 
EGFR was demonstrated by co-
immunoprecipitation and affinity pull-down assays 
(Ng et al. 2009). Silencing of Rab31 did not impact 
internalization of EGFR or its entry in early 
endosomes, but strongly affected EGFR-transition 
between early and late endosomes (Chua and Tang 
2014). Furthermore, EEA1, a multi-domain tethering 
factor involved in the fusion of endosomes, also 
colocalizes with Rab31 suggesting that EEA1 is 
directly involved in Rab31/EGFR interaction and, by 
this, is important for Rab31-regulated trafficking of 
the EGFR between early and late endosomes. 
Interestingly, silencing of GAPVD1 (Gapex-5), a 
Rab GEF, reduced Rab31/EGFR interaction and 
abrogated Rab31-mediated enhancement of EGFR 
trafficking (Chua and Tang 2014). 
- Membrane curvature protein APPL2 
Additionally, Rab31, together with other members of 
the Rab5 subfamily (Rab5a, Rab22a, Rab24, see Fig. 
2B), has also been shown to bind the membrane-
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curving protein APPL2 (adaptor protein, 
phosphotyrosine interaction, pleckstrin homology 
(PH) domain, and leucine zipper-containing 
protein). APPL2 is associated with a distinct 
subpopulation of early endosomes that link cell 
surface signaling and endocytosis (King et al. 2012). 
In macrophages, Rab31 and its effector APPL2 are 
largely confined to phagosomal membranes 
displaying important roles in phagosome closure and 
FcγR signaling (Yeo et al. 2015) 
- Rab31 and glucose uptake. 
In adipocytes, insulin-stimulated glucose uptake is 
mediated by the glucose transporter SLC2A4 
(GLUT4). In the absence of insulin, Gapex-5 
appears to function as a Rab31-GEF maintaining 
Rab31 in its active state which leads to intracellular 
retention of GLUT4. Upon insulin stimulation, 
Gapex-5 in complex with another protein, the 
membrane curvature protein TRIP10 (CIP4), 
translocates to the plasma membrane resulting in 
decreased activity of TGN-associated Rab31. In 
consequence, GLUT4 is translocated to the plasma 
membrane, where it enables increased glucose 
uptake into the cell (Lodhi et al. 2007). Recently, 
another Rab31-regulating protein, NGFR (the p75 
neutrophin receptor (p75NTR)), has been identified 
(Baeza-Raja et al. 2012). Similar to Gapex-5, p75NTR 
supports retention of GLUT4 in intracellular 
vesicles, thus decreasing glucose uptake. Whereas 
Gapex-5 acts as a GEF, p75NTR may function as a 
GDI displacement factor, which activates Rab31 by 
displacing it from its GDIs. 
 Factors regulating Rab expression 
mRNA binding protein HuR. 
The ubiquitously expressed mRNA binding protein 
ELAVL1 (HuR) is a member of the Hu/ELAV-
family encompassing four members, HuR, ELAVL2 
(HuB or HelN1), ELAVL3 (HuC), and ELAVL4 
(HuD). It has been proposed to interact with a series 
of cancer-relevant genes, thereby stabilizing and 
translationally enhancing its mRNA targets and, 
furthermore, modulating their transport between the 
nucleus and the cytoplasm (Cataluce et al. 2010). In 
fact, overexpression and/or high cytoplasmic HuR 
levels (representing the functional pool) are 
associated with poor outcome in several types of 
cancer including breast cancer (Wang et al 2013, 
Heinonen et al 2005). In addition, increased 
cytoplasmic HuR expression was found to be linked 
to tamoxifen resistance of MCF7 breast cancer cells 
(Hostetter et al. 2008). Silencing of HuR leads to the 
downregulation of Rab31 protein in breast epithelial 
184B5Me cells. Furthermore, HuR was 
demonstrated to directly bind to Rab31 mRNA both 
in 184B5Me and breast cancer MCF7 cells 
(Heinonen et al. 2011). 
Mucin 1 C-terminal subunit (MUC1-C). 
MUC1 (Mucin 1), which is overexpressed in most 
human breast cancers, is a heterodimeric 
transmembrane glycoprotein, generated by 
autocleavage of a single polypeptide (Kufe 2009; 
2013). The extracellular N-terminal chain, MUC1-
N, contains the O-glycosylated tandem repeats, 
which are typical for mucin family members. 
MUC1-N is linked to the cell surface via formation 
of a non-covalent complex with the C-terminal 
subunit, MUC1-C, comprising a short 58 aa 
extracellular region, a 28 aa transmembrane domain, 
and a 72 aa cytoplasmic tail. The cytoplasmic 
domain of MUC1-C interacts with various receptor 
tyrosine kinases such as EGFR and ERBB2 (HER2) 
and, by this, may modulate downstream signaling 
pathways (Kufe 2009; 2013). MUC1-C has been 
demonstrated to be internalized by clathrin-mediated 
endocytosis. Overexpression of mucin 1 in breast 
cancer is associated with targeting of the 
cytoplasmic MUC1-C to the nucleus, where it 
interacts with ESR1 (estrogen receptor α ERα) and 
stimulates ERα-mediated gene transcription. One of 
the target genes activated by the ERα/MUC1-C 
complex is RAB31, the promotor of which contains 
an ER-responsive element (Jin et al. 2012). 
Interestingly, Rab31 in turn stimulates upregulation 
of MUC1-C, likely by attenuating degradation of 
MUC1-C in lysosomes. In line with these results, 
Rab31 and MUC1-C are significantly co-expressed 
in ER-positive tissues of breast cancer patients (Jin 
et al. 2012). In a more recent study, MUC1-C was 
reported to block inhibitory effects of tamoxifen on 
ERα-mediated Rab31 promoter activity in breast 
cancer cells (Kharbanda et al. 2013). 
Homology 
Rab31 belongs to the large Rab protein family (66 
human members) of the Ras superfamily of small 
GTPases. The Rabs can be subdivided into six 
supergroups, with human Rab31 belonging to group 
II encompassing nine human members: the 
quadrupled Rabs RAB5A, RAB5B, RAB5C, and 
RAB17; the duplicated RAB31 and RAB22A; the 
duplicated RAB24 and RAB20; as well as RAB21 
(Klöpper et al. 2012). Rab31 displays 71.1% identity 
(86.1% similarity) with Rab22A, whereas for the 
other members of the superfamily the identity ranges 
from about 35-45% (with similarities between about 
70-78%). An alignment of the nine members of the 
group II superfamily is given in Fig. 2B. 
Implicated in 
Breast cancer 
Disease 
Clinical relevance/prognosis.  RAB31 is among 11 
genes found to be overexpressed in tumor tissue of 
estrogen receptor (ER)-positive breast cancer 
patients by microarray analyses (Abba et al. 2005). 
Furthermore, RAB31 is one of seven genes that were 
identified to be strongly upregulated in breast cancer 
RAB31 (Ras-related protein in brain 31) Kotzsch M, et al. 
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tissue with high expression of the urokinase receptor 
(uPAR) splice variant uPAR-del4/5. Similar to 
uPAR-del4/5, high Rab31 mRNA transcript levels 
were significantly associated with distant metastasis-
free survival and overall survival in 280 lymph node-
negative breast cancer patients (Kotzsch et al. 2008). 
Since Rab31 mRNA independently contributed to 
the base multivariate models it may serve as a novel 
prognostic marker in breast cancer. Moreover, the 
independent but additive prognostic relevance of 
mRNA expression levels of both, uPAR-del4/5 and 
rab31, in node-negative breast cancer patients might 
improve prediction of disease recurrence in breast 
cancer. 
 
Table 1. Characteristics of breast cancer cells 
expressing low versus high levels of Rab31 
Elevated Rab31 levels in breast cancer cells lead in vitro to 
increased proliferation, but decreased adhesion and 
invasion and in vivo to a strongly reduced lung colonization 
capacity. 
Oncogenesis 
 Tumorbiological relation with uPAR.  Not only 
Rab31 mRNA but also PLAUR (uPAR) mRNA is 
regulated/stabilized by the RNA binding protein 
HuR both in vitro and in vivo (Heinonen et al. 2011, 
Tran et al. 2003).  
Therefore, the observed elevated uPAR-del4/5 as 
well as Rab31 expression in metastasizing breast 
cancer may be due to increased HuR expression in 
these tumors and points to a possible relationship 
between Rab31 and the uPA/uPAR system in cancer 
cells. Another interesting link between uPAR and 
Rab31 is the fact that uPAR interacts with the cation-
independent mannose-6-phosphate receptor, CI-
M6PR (Nykjaer et al. 1998, Kreiling et al. 2003). 
Interaction of uPAR with CI-M6PR was proposed to 
be involved in the turnover of uPAR by directing the 
receptor to endosomes for degradation and, thus, to 
regulate the cell surface concentration of uPAR as 
well as internalizing uPAR when it interacts with 
uPA (Nykjaer et al. 1998). Whether the relationship 
between uPAR and CI-M6PR might relate to the role 
of Rab31 in cancer is, however, not yet clear. 
Possibly, due to its regulatory function in 
intracellular M6PR trafficking, Rab31 may modulate 
uPAR activity in cell signaling pathways and/or 
extracellular matrix interactions/degradation. 
 Cellular localization.  Protein expression of Rab31 
was shown in breast cancer tissue by 
immunohistochemistry using highly specific 
antibodies for Rab31 (Grismayer et al. 2012). A 
weak to moderate cytoplasmic staining for Rab31 
and, occasionally, strong perinuclear and/or nuclear 
staining of cancer cells was observed, whereas 
stromal cells were less frequently stained. Using 
immunocytochemistry, a pronounced perinuclear 
staining in MDA-MB-231 breast cancer cells 
overexpressing Rab31 was found, which was similar 
to other immunocytochemical studies, showing a 
perinuclear patch of Rab31 in the trans-Golgi region 
in different cell types (Grismayer et al. 2012, Ng et 
al. 2007, Ng et al. 2009). 
 Modulation of tumorbiological-relevant 
processes. Grismayer et al. (2012) characterized the 
phenotype of breast cancer cell transfectants with 
different Rab31 expression levels in vitro. Elevated 
Rab31 protein levels were associated with enhanced 
cell proliferation. Interestingly, weak to moderate 
overexpression of Rab31 in cell lines with no 
detectable endogenous Rab31 expression was 
already sufficient to elicit distinct effects on cell 
proliferation (Grismayer et al. 2012). Inversely, 
when Rab31 mRNA levels were stably knocked 
down by short hairpin RNA interference (shRNAi) 
in breast cancer cells, which express moderate 
endogenous Rab31 levels, reduction of Rab31 
mRNA/protein expression led to lower cell 
proliferation rates (S. Soelch and V. Magdolen, 
unpublished). Additionally, increased expression of 
Rab31 led to reduced adhesion of cells towards 
extracellular matrix proteins and decreased invasive 
capacity through MatrigelTM (Grismayer et al. 2012). 
In contrast to wild-type Rab31, overexpression of a 
Rab31 mutant unable to insert into the Golgi 
membrane, due to deletion of the two C-terminal 
cysteine residues (Rab31-ΔCC), did not affect in 
vitro proliferation, adhesion, or invasion (S. Soelch 
and V. Magdolen, unpublished). 
In a xenograft mouse model, the number of lung 
metastases was found to be significantly reduced in 
those mice which were inoculated into the tail vein 
with Rab31-overexpressing cells compared to mice 
injected with vector control cells expressing basal 
levels of Rab31 (Grismayer et al. 2012). Considering 
the fact that high levels of Rab31 mRNA in tumor 
tissue of breast cancer patients are significantly 
associated with poor prognosis, this finding at first 
sight is unexpected.  
During tumor progression, however, cancer cells 
typically acquire different malignant phenotypes: (i) 
in the initial phase, the growth of the primary tumor, 
a high proliferation rate is observed and 
angiogenesis takes place; (ii) then, in order to 
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metastasize, tumor cells switch to an invasive and 
motile phenotype leaving their site of origin to 
generate micrometastases; (iii) finally, at the 
metastatic site, the proliferative phenotype has to be 
recovered to trigger growth again (Gao et al. 2005). 
Rab31, depending on its expression level, may thus 
modulate a switch between a more proliferative vs. 
invasive phenotype in breast cancer cells (Tab. 1). 
Interestingly, it was reported that high levels of the 
mRNA binding protein HuR which binds and 
stabilizes Rab31 mRNA (see above), on one hand, 
lead to increased proliferation and altered cell cycle 
kinetics in breast cancer cells. On the other, HuR 
overexpression significantly reduced tumor growth 
in orthotopic mouse models (Gubin et al. 2010), 
observations, which are in line with the reported 
effects of Rab31 overexpression in breast cancer 
cells. 
Using microarray analyses, Rab31 overexpression in 
breast cancer cells was recently shown to modulate 
expression of other tumor biologically relevant 
genes, especially genes of the TGF-β superfamily 
(Soelch and Magdolen, unpublished). Thus, Rab31 
may represent a major player in the change of the cell 
biological phenotype of breast cancer cells by 
affecting mainly (non-)canonical TGF-β signaling 
pathways. 
Cervical cancer 
RAB 31 was identified by microarray analyses 
among six genes that associate with tumor 
expression in the cervical cancer HeLa cell line 
overexpressing the centrosomal transforming acidic 
coiled coil TACC3 protein (Yim et al. 2009). 
Furthermore, Rab31 has been shown to play an 
important role in cervical cancer progression (Pan et 
al. 2015). Rab31 overexpression promoted cell 
proliferation in U87 and SiHa cervical cancer cell 
lines via activation of G1/S checkpoint transitions, 
and inhibited cell apoptosis. Moreover, Rab31 
overexpression improved U87 and SiHa cancer cell 
migration, and induced the mRNA expression of 
epithelial-to mesenchymal transition (EMT) 
biomarkers depending on the ERK1/2 and AKT 
pathway. Contrariwise, Rab31 knockdown reduced 
the growth of U87 and SiHa cells in a nude mouse 
model in vivo. 
Ovarian cancer 
In a study evaluating the effects of 17β-estradiol (E2) 
on the transcriptional level of altered genes in the 
estrogen receptor (ER)-positive BG-1 ovarian cancer 
cell line by microarray analyses, RAB31 was among 
five genes that were significantly upregulated upon 
treatment with E2 (Hwang et al. 2011).  In parallel 
with the microarray results, the mRNA levels of 
these genes were significantly induced by E2 
(Hwang et al. 2011). With regard to its clinical 
relevance in ovarian cancer, Rab31 mRNA 
expression has been analyzed in a cohort of 103 
advanced ovarian cancer patients, however, no 
significant association of Rab31 mRNA levels with 
progression-free and overall survival of ovarian 
cancer patients was found (Kotzsch et al.  2011). 
Liver cancer 
Recently, Rab31 was detected by 
immunohistochemistry in 94 of 96 tumor tissue 
samples of patients with hepatocellular carcinoma 
(HCC), and significantly higher Rab31 expression 
were observed in HCC tissue as compared to the 
adjacent non-malignant liver tissue (Sui et al. 2015). 
High immunoexpression of Rab31 was associated 
with worse prognosis after curative liver resection 
and was found to be an independent prognostic 
factor in HCC. Furthermore, the possible role of 
Rab31 on HCC progression was examined in 
different HCC cell lines in vitro. Overexpression of 
Rab31 in the HCC cell line Huh7 enhanced cell 
growth and inhibited cell apoptosis. Consistently, 
silencing of Rab31 in HCC cell line MHCC97 
increased apoptosis and suppressed cell viability and 
cell proliferation. These data suggest that Rab31 may 
promote HCC cell proliferation by suppressing cell 
apoptosis (Sui et al. 2015). 
Glioblastoma 
RAB31, among others, has been reported as a gene 
showing a cohort (race)-dependent association with 
progression-free survival in glioblastoma (Serão et 
al. 2011). In a meta-analysis of microarray studies 
using Bayesian network analysis, aimed at 
identifying key genes involved in development of 
astrocytic tumors, RAB31 was identified as one out 
of ten upregulated genes that were found to be most 
influential to development of the highest grade of 
astrocytoma, Glioblastoma multiforme (Kunkle et 
al. 2013). Differential expression of all ten genes, 
including RAB31, at once, increased the lifetime risk 
of developing glioblastoma to 85.9%, demonstrating 
the value of Rab31 as biomarker in Glioblastoma 
multiforme. Interestingly, significant levels of 
Rab31 were found in neural progenitor cells (NPC), 
which are believed to be the cells of origin of 
glioblastoma tumor stem cells (Chua et al. 2014). 
While overexpression of Rab31 enhanced, silencing 
hindered the differentiation of NPC to astrocytes 
suggesting an important role of Rab31 in astroglial 
differentiation (Chua et al. 2014).  
Rab31 protein is rather specifically expressed in 
GFAP-positive mature astrocytes of adult rodent 
brains, and is localized mainly in the cell body of 
astrocytes, and not in the astrocytic processes (Ng et 
al. 2009). Whereas elevated levels of Rab31 promote 
cell proliferation in breast or liver cancer cells, in the 
astroglial cell line A431, Rab31 silencing increased 
cell proliferation rates compared to the vector 
control, and vice versa, moderate overexpression of 
RAB31 (Ras-related protein in brain 31) Kotzsch M, et al. 
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Rab31 led a reduced cell proliferation (Ng et al. 
2009). Since Rab31 in A431 cells also plays a role in 
regulating EGFR trafficking, one may suggest that 
altering Rab31 levels affect EGFR traffic leading to 
an influence on cell proliferation (Ng et al. 2009). 
Skin diseases 
In psoriasis, a complex inflammatory skin disease, 
gene expression profiling was used to determine the 
extent to which the genomic psoriasis phenotype, as 
defined by the differentially expressed genes 
between lesional and non-lesional skin, was reversed 
after treatment with the tumor necrosis factor (TNF) 
blocker etarnecept in responding patients (Suarez-
Farinas et al. 2011). Rab31 was found to be increased 
in psoriasis tissue but did not fully return to the non-
lesional levels after treatment. 
Immunohistochemically, there were many Rab31 
positive cells in the papillary dermis of lesional skin, 
with fewer positive cells in non-lesional skin. 
Lowest Rab31 immunoexpression was observed in 
normal skin. In lesional skin, Rab31 was expressed 
on CD45+ cells, and also some CD11c+ myeloid 
dendritic cells and few CD163+ macrophages 
(Suarez-Farinas et al. 2011).  
Rebane et al. (2012) analyzed the differential 
expression profile of apoptosis-related genes in 
keratinocytes of atopic dermatitis (AD) vs. normal 
skin, and the upregulation of immune system-related 
genes in tissue of chronic AD lesions. RAB31 was 
one of eight differentially expressed genes that were 
found upregulated in lesional skin tissue of AD 
patients suggesting the involvement of Rab31, 
among other new apoptosis- and inflammation-
related factors, in the pathogenesis of AD, especially 
in long-lasting and refractory cases of the disease 
(Rebane et al. 2012). 
Other disease-related findings 
Kidney.  Liu et al. (2015) used micro RNA (miRNA) 
microarray analyses for investigation of the 
molecular mechanisms of kidney aging. Several Rab 
proteins including Rab1a and Rab31 were targeted 
by miR-184and miR-150. Both miRNAs were 
significantly increased in aging glomerular 
mesangial cells (GMC) vs. young cells, while Rab31 
was significantly lower in aging cells. Transfection 
of miRNAs into young GMCs suppressed the 
expression of Rab1a and Rab31, transfected cells 
showed lower autophagy activities and higher levels 
of cellular oxidative products, leading to the aging of 
young GMCs. Otherwise, inhibitors promoted 
autophagy and reduced oxidative damage by 
upregulation of Rab1a and Rab31 in old GMCs. This 
suggests a role of Rab31 in miRNA-inhibited 
autophagy and promotion of GMC aging (Liu et al. 
2015).  
 Cancer-associated fibroblasts.  Bozóky et al. 
(2013) characterized differentially expressed 
proteins in the stroma of basal cell carcinoma vs. 
normal skin fibroblasts. Rab31 was found as one 
from a panel of twelve proteins that were 
differentially expressed in cancer-associated 
fibroblasts (CAF) of basal cell carcinoma but not in 
normal skin fibroblasts. Besides basal cell 
carcinoma, Rab31-expressing CAFs were found in a 
relatively high percentage of tumor samples 
originating from different tumor types such as 
squamous cell carcinoma, colorectal, breast, and - to 
lower extent - lung cancer. Rab31 was not expressed 
in several types of normal fibroblasts or 
myofibroblast-like cells in normal tissues (breast, 
bone marrow, kidney) except for subepithelial 
fibroblasts of small intestine villi (Bozóky et al. 
2013). 
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